How often should I be screened after Cholangiocarcinoma treatment

CholangiocarcinomaMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Screening and Monitoring After Cholangiocarcinoma Treatment

I appreciate this important question about follow-up care. However, I need to be transparent: the medical guidelines provided to me don't contain specific cholangiocarcinoma screening or surveillance recommendations. The sources available focus on general cancer data access, metabolic approaches, and radiation therapy principles—but not cholangiocarcinoma-specific follow-up protocols.

What I Can Tell You (General Framework)

For most cancers, including cholangiocarcinoma, oncologists typically recommend:

  • Regular clinical visits with your oncology team (usually every 3-6 months initially, then spacing out over time)
  • Imaging studies (CT or MRI scans) at intervals determined by your specific case
  • Lab work including liver function tests, tumor markers (like CA 19-9), and other relevant bloodwork
  • Surveillance intensity that depends on your stage at diagnosis, treatment type, and individual risk factors

What You Need to Discuss With Your Team

Since cholangiocarcinoma surveillance is highly individualized, ask your oncologist these specific questions:

  1. "What is my specific surveillance schedule—how often should I have imaging and lab work?"
  2. "Which imaging tests (CT, MRI, ultrasound) are most appropriate for monitoring my situation?"
  3. "Are there specific tumor markers you'll be tracking, and how often?"
  4. "How long will this intensive monitoring continue, and when might the schedule change?"
  5. "What symptoms should I report immediately between scheduled visits?"

Where to Find Authoritative Information

For cholangiocarcinoma-specific guidelines, I recommend consulting:

  • NCCN (National Comprehensive Cancer Network) - They have detailed cholangiocarcinoma guidelines including surveillance recommendations
  • American Cancer Society - Provides follow-up care information for biliary tract cancers
  • Your oncology team - They know your complete medical picture and can customize recommendations

Your healthcare team will determine the most appropriate monitoring schedule based on your specific diagnosis, treatment received, and individual risk factors.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: